At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor Development
In Brief
A clinical study evaluating Hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma) for Vitamin B 12 Deficiency. Completed, enrolled 107 participants across 1 site.
Detailed Summary
Adequate levels of vitamin B12 (cobalamin) is necessary for normal growth and development in infants. We have earlier investigated cobalamin status in healthy children and we observed metabolic evidence of impaired cobalamin status during the first 6 months, but not later in life. The purpose of this study is to determine if cobalamin supplementation may influence the metabolic profile related to cobalamin status in infants.
Study Details
Timeline
Interventions
an intramuscular injection of 400 µg hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma, Norway)